Peginterferon α-2b in the treatment of hepatitis C

ISSN： 1746-0794

Source： Future Virology, Vol.1, Iss.3, 2006-05, pp. : 279-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon-α_2a for the treatment of hepatitis B infection

By Cooksley W Graham E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1373-1380

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon-α_2a in the treatment of chronic hepatitis C

By Akimov Sergey Adeyemi Oluwatoyin M

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 689-701

Future Medicine

Access to resources Recommend Favorite

Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b

By Foster Graham R.

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 147-165

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2a + ribavirin: shorter treatment duration inferior in hepatitis C

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b + ribavirin for hep C during methadone treatment

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite